{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:27:07Z","timestamp":1787837227657,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite recent therapeutic advancements, ischemic stroke remains a major cause of death and disability. It has been previously demonstrated that \u2009~\u200985-kDa recombinant human perlecan domain V (rhPDV) binds to upregulated integrin receptors (\u03b12\u03b21 and \u03b15\u03b21) associated with neuroprotective and functional improvements in various animal models of acute ischemic stroke. Recombinant human perlecan laminin-like globular domain 3 (rhPDV<jats:sub>LG3<\/jats:sub>), a 21-kDa C-terminal subdomain of rhPDV, has been demonstrated to more avidly bind to the \u03b12\u03b21 integrin receptor than its parent molecule and consequently was postulated to evoke significant neuroprotective and functional effects. To test this hypothesis, fifty male C57Bl\/6\u00a0J mice studied in a t-MCAO model were randomly allocated to either rhPDV treatment, rhPDV<jats:sub>LG3<\/jats:sub>, or equivalent volume of PBS at the time of reperfusion in a study where all procedures and analyses were conducted blind to treatment. On post-MCAO day 7, <jats:italic>2,3,5-triphenyltetrazolium chloride<\/jats:italic> staining of brain slices was used to quantify infarct volume. We observed that treatment with rhPDV<jats:sub>LG3<\/jats:sub> reduced infarct volume by 65.6% (<jats:italic>p<\/jats:italic>\u2009=\u20090.0001), improved weight loss (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and improved functional outcome measures (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) when compared to PBS controls, improvements which were generally greater in magnitude than those observed for 2\u00a0mg\/kg of rhPDV. In addition, treatment with 6\u00a0mg\/kg of rhPDV<jats:sub>LG3<\/jats:sub> was observed to significantly reduce mortality due to stroke in one model, an outcome not previously observed for rhPDV. Our initial findings suggest that treatment with rhPDV<jats:sub>LG3<\/jats:sub> provides significant improvement in neuroprotective and functional outcomes in experimental stroke models and that further investigation of rhPDV<jats:sub>LG3<\/jats:sub> as a novel neuroprotective therapy for patients with stroke is warranted.<\/jats:p>","DOI":"10.1007\/s12975-022-01089-2","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T07:05:46Z","timestamp":1670828746000},"page":"941-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant Human Perlecan DV and Its LG3 Subdomain Are Neuroprotective and Acutely Functionally Restorative in Severe Experimental Ischemic Stroke"],"prefix":"10.1007","volume":"14","author":[{"given":"Ifechukwude Joachim","family":"Biose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibolya","family":"Rutkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Clossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Schechtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-0016","authenticated-orcid":false,"suffix":"IV","given":"H. Davis","family":"Adkisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-9553","authenticated-orcid":false,"given":"Gregory J.","family":"Bix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"issue":"11","key":"1089_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"Group GBDNDC.; GBD 2015 Neurological Disorders Collaborator Group","year":"2017","unstructured":"Group GBDNDC.; GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877\u201397.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1089_CR2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association external icon. Circulation. 2020;141(9):e139\u2013596.","journal-title":"Circulation"},{"issue":"9","key":"1089_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/neurintsurg-2015-011971","volume":"7","author":"AT Rai","year":"2015","unstructured":"Rai AT. Red pill, blue pill: reflections on the emerging large vessel stroke \u2018market\u2019. J Neurointerv Surg. 2015;7(9):623\u20135.","journal-title":"J Neurointerv Surg"},{"issue":"3","key":"1089_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/neurintsurg-2018-014640","volume":"11","author":"M Mokin","year":"2019","unstructured":"Mokin M, Ansari SA, McTaggart RA, et al. Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee. J Neurointerv Surg. 2019;11(3):215\u201320.","journal-title":"J Neurointerv Surg"},{"key":"1089_CR5","doi-asserted-by":"publisher","first-page":"10588","DOI":"10.1038\/s41598-020-67448-x","volume":"10","author":"C Laredo","year":"2020","unstructured":"Laredo C, Ren\u00fa A, Llull L, et al. Elevated glucose is associated with hemorrhagic transformation after mechanical thrombectomy in acute ischemic stroke patients with severe pretreatment hypoperfusion. Sci Rep. 2020;10:10588.","journal-title":"Sci Rep"},{"key":"1089_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/STROKEAHA.118.023769","volume":"50","author":"A Chamorro","year":"2019","unstructured":"Chamorro A, Brown S, Amaro S, et al. Glucose modifies the effect of endovascular thrombectomy in patients with acute stroke. Stroke. 2019;50:690\u20136.","journal-title":"Stroke"},{"issue":"5","key":"1089_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12975-013-0266-1","volume":"4","author":"G Bix","year":"2013","unstructured":"Bix G, Gowing EK, Clarkson AN. Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice. Transl Stroke Res. 2013;4(5):515\u201323.","journal-title":"Transl Stroke Res"},{"key":"1089_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12975-020-00800-5","volume":"12","author":"A Trout","year":"2021","unstructured":"Trout A, Kahle MP, Roberts JM, et al. Perlecan domain-V enhances neurogenic brain repair after stroke in mice. Transl Stroke Res. 2021;12:72\u201386.","journal-title":"Transl Stroke Res"},{"key":"1089_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2013.08.004","volume":"34","author":"MC Farach-Carson","year":"2013","unstructured":"Farach-Carson MC, Warren CR, Harrington DA, Carson DD. Border patrol: insights into the unique role of perlecan\/heparan sulfate proteoglycan 2 at the cell and tissue borders. Matrix Biol. 2013;34:64\u201379.","journal-title":"Matrix Biol"},{"issue":"2","key":"1089_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jmb.2011.09.048","volume":"414","author":"V Le","year":"2011","unstructured":"Le V, Kim H, Choi J, Kim JH, Hahn MJ, Lee C, Kim KK, Hwang HY. Crystal structure of the LG3 domain of endorepellin, an angiogenesis inhibitor. J Mol Biol. 2011;414(2):231\u201342.","journal-title":"J Mol Biol"},{"issue":"4","key":"1089_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.STR.0000119383.76447.05","volume":"35","author":"S Fukuda","year":"2004","unstructured":"Fukuda S, Fini CA, Mabuchi T, et al. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke. 2004;35(4):998\u20131004.","journal-title":"Stroke"},{"issue":"7","key":"1089_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00004647-200107000-00009","volume":"21","author":"M Takaya","year":"2001","unstructured":"Takaya M, Haring HP, Stuiver I, Wagner S, Abumiya T, Lucero J, Lee P, Copeland BR, Seiffert D, del Zoppo GJ. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab. 2001;21(7):835\u201346.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1089_CR13","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1172\/JCI46358","volume":"121","author":"B Lee","year":"2011","unstructured":"Lee B, Clarke D, Al Ahmad A, Kahle M, Parham C, et al. Perlecan domain V is neuroprotective and pro-angiogenic following ischemic brain stroke in rodents. JCI. 2011;121:3005\u201323.","journal-title":"JCI"},{"issue":"11","key":"1089_CR14","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1177\/0271678X17709185","volume":"37","author":"N Percie du Sert","year":"2017","unstructured":"Percie du Sert N, Alfieri A, Allan SM, Carswell HV, Deuchar GA, Farr TD, Flecknell P, Gallagher L, Gibson CL, Haley MJ, Macleod MR, McColl BW, McCabe C, Morancho A, Moon LD, O\u2019Neill MJ, P\u00e9rez de Puig I, Planas A, Ragan CI, Rosell A, et al. The IMPROVE guidelines (ischaemia models: procedural refinements of in vivo experiments). J Cereb Blood Flow Metab. 2017;37(11):3488\u2013517.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1089_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00004647-200002000-00016","volume":"20","author":"J Aronowski","year":"2000","unstructured":"Aronowski J, Grotta JC, Strong R, Waxham MN. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20(2):343\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1089_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3995\/jstroke.8.1","volume":"8","author":"JYY Koizumi","year":"1986","unstructured":"Koizumi JYY, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1\u20138.","journal-title":"Jpn J Stroke"},{"key":"1089_CR17","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1161\/01.STR.25.11.2235","volume":"25","author":"J Aronowski","year":"1994","unstructured":"Aronowski J, Samways E, Strong R, Grotta JC. A graded bioassay for demonstration of brain rescue from experimental acute ischemia. Stroke. 1994;25:2235\u201340.","journal-title":"Stroke"},{"issue":"2","key":"1089_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3233\/JAD-130683","volume":"38","author":"C Parham","year":"2014","unstructured":"Parham C, Auckland L, Rachwal J, Clarke D, Bix G. Perlecan domain V inhibits amyloid-B induced brain endothelial cell toxicity and restores angiogenic function. J Alzheimers Dis. 2014;38(2):415\u201323.","journal-title":"J Alzheimers Dis"},{"key":"1089_CR19","doi-asserted-by":"publisher","unstructured":"Gaire BP, Subedi L, Teramato H, Hu B. The role of cathepsin B is ischemia-reperfusion injury after stroke. In: Plutka R, editor. Cerebral Ischemia. Brisbane: Exon Publications, 2021. https:\/\/doi.org\/10.36255\/exonpublications.cerebralischemia.2021.cathepsin.","DOI":"10.36255\/exonpublications.cerebralischemia.2021.cathepsin"},{"issue":"40","key":"1089_CR20","doi-asserted-by":"publisher","first-page":"27220","DOI":"10.1074\/jbc.M801164200","volume":"283","author":"JF Cailhier","year":"2008","unstructured":"Cailhier JF, Sirois I, Laplante P, et al. Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem. 2008;283(40):27220\u20139.","journal-title":"J Biol Chem"},{"key":"1089_CR21","doi-asserted-by":"publisher","unstructured":"Parker TJ, et al. A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activity. PLoS One. 2012; 7(3): e33714. Published online 2012 Mar 23. https:\/\/doi.org\/10.1371\/journal.pone.0033714.","DOI":"10.1371\/journal.pone.0033714"},{"issue":"1","key":"1089_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1586\/14789450.2014.859527","volume":"11","author":"DL Sampson","year":"2014","unstructured":"Sampson DL, Broadbent JA, Parker AW, Upton Z, Parker TJ. Urinary biomarkers of physical activity: candidates and clinical utility. Expert Rev Proteomics. 2014;11(1):91\u2013106.","journal-title":"Expert Rev Proteomics"},{"issue":"9","key":"1089_CR23","doi-asserted-by":"publisher","first-page":"e45257","DOI":"10.1371\/journal.pone.0045257","volume":"7","author":"DN Clarke","year":"2012","unstructured":"Clarke DN, Al Ahmad A, Lee B, Parham C, Auckland L, Fertala A, Kahle M, Shaw CS, Roberts J, Bix GJ. Perlecan domain V induces VEGf secretion in brain endothelial cells through integrin \u03b15\u03b21 and ERK-dependent signaling pathways. PLoS ONE. 2012;7(9):e45257.","journal-title":"PLoS ONE"},{"issue":"4","key":"1089_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","volume":"86","author":"PJ Magistretti","year":"2015","unstructured":"Magistretti PJ, Allenon I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86(4):883\u2013901.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"1089_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000508054","volume":"75","author":"P Steiner","year":"2019","unstructured":"Steiner P. Brain fuel utilization in the developing brain. Ann Nutr Metab. 2019;75(Suppl 1):8\u201318.","journal-title":"Ann Nutr Metab"},{"issue":"10","key":"1089_CR26","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1083\/jcb.201807178","volume":"218","author":"K Nakamura","year":"2019","unstructured":"Nakamura K, Ikeuchi T, Nara K, Rhodes CS, Zhang P, Chiba Y, et al. Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. J Cell Biol. 2019;218(10):3506\u201325.","journal-title":"J Cell Biol"},{"key":"1089_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/156720212799297100","volume":"9","author":"K Arimura","year":"2012","unstructured":"Arimura K, Ago T, Kamouchi M, Nakamura K, Ishitsuka K, Kuroda J, Sugimori H, Ooboshi H, Sasaki T, Kitazono T. PDGF receptor \u03b2 signaling in pericytes following ischemic brain injury. Curr Neurovasc Res. 2012;9:1\u20139.","journal-title":"Curr Neurovasc Res"},{"key":"1089_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2015.11.003","volume":"1630","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Arimura K, Nishimura A, Tachibana M, Yoshikawa Y, Makihara N, Wakisaka Y, Kuroda J, Kamouchi M, Ooboshi H, et al. Possible involvement of basic FGF in the upregulation of PDGFR\u03b2 in pericytes after ischemic stroke. Brain Res. 2016;1630:98\u2013108.","journal-title":"Brain Res"},{"issue":"2","key":"1089_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/jcbfm.2011.136","volume":"32","author":"J Shen","year":"2012","unstructured":"Shen J, Ishii Y, Xu G, et al. PDGFR-\u03b2 as a positive regulator of tissue repair in a mouse model of focal cerebral ischemia. J Cereb Blood Flow Metab. 2012;32(2):353\u201367.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1089_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1017\/S1431927611012402","volume":"18","author":"AN Stratman","year":"2011","unstructured":"Stratman AN, Davis GE. Endothelial cell pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal. 2011;18(1):68\u201386.","journal-title":"Microsc Microanal"},{"issue":"5","key":"1089_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3109\/03008207.2015.1066781","volume":"56","author":"GE Davis","year":"2015","unstructured":"Davis GE, Norden PR, Bowers SLR. Molecular control of capillary morphogenesis and maturation by xx and remodeling of the extracellular matrix: functional roles of endothelial cells and pericytes in health and disease. Connective Tissue Res. 2015;56(5):392\u2013402.","journal-title":"Connective Tissue Res"},{"key":"1089_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.07.014","volume":"180","author":"M Campisi","year":"2018","unstructured":"Campisi M, Shin Y, Osaki T, et al. 3D self-organized microvascular model of the human blood brain barrier with endothelial cells, pericytes, and astrocytes. Biomaterials. 2018;180:117\u201329.","journal-title":"Biomaterials"},{"issue":"6","key":"1089_CR33","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/STROKEAHA.118.020927","volume":"49","author":"A Hoffmann","year":"2018","unstructured":"Hoffmann A, Dege T, Kunze R, Ernst AS, Lorenz H, B\u00f6hler LI, Korff T, Marti HH, Heiland S, Bendszus M, Helluy X, Pham M. Early blood-brain barrier disruption in ischemic stroke initiates multifocally around capillaries\/venules. Stroke. 2018;49(6):1479\u201387.","journal-title":"Stroke"},{"issue":"8","key":"1089_CR34","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1161\/STROKEAHA.116.016356","volume":"48","author":"H Hosoo","year":"2017","unstructured":"Hosoo H, Marushima A, Nagasaki Y, Hirayama A, Ito H, Puentes S, Mujagic A, Tsurushima H, Tsuruta W, Suzuki K, Matsui H, Matsumaru Y, Yamamoto T, Matsumura A. Neurovascular unit protection from cerebral ischemia-reperfusion injury by radical-containing nanoparticles in mice. Stroke. 2017;48(8):2238\u201347.","journal-title":"Stroke"},{"issue":"41","key":"1089_CR35","doi-asserted-by":"publisher","first-page":"30383","DOI":"10.1074\/jbc.M606412200","volume":"281","author":"P Laplante","year":"2006","unstructured":"Laplante P, Raymond MA, Labelle A, Abe J, Iozzo RV, H\u00e9bert MJ. Perlecan proteolysis induces an alpha2beta1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J Biol Chem. 2006;281(41):30383\u201392.","journal-title":"J Biol Chem"},{"key":"1089_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/stem.403","volume":"28","author":"M Soulez","year":"2010","unstructured":"Soulez M, Sirois I, Brassard N, et al. Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells coordinately activate ERK1\/2-dependent anti-apoptotic pathways in mesenchymal stem cells. Stem Cells. 2010;28:810\u201320.","journal-title":"Stem Cells"},{"issue":"4","key":"1089_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0271678X17722108","volume":"38","author":"Y Izawa","year":"2018","unstructured":"Izawa Y, Gu YH, Osada T, Kanazawa M, Hawkins BT, Koziol JA, Papayannopoulou T, Spatz M, Del Zoppo GJ. \u03b21-integrin-matrix interactions modulate cerebral microvessel endothelial cell tight junction expression and permeability. J Cereb Blood Flow Metab. 2018;38(4):641\u201358.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"1089_CR38","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1111\/febs.12164","volume":"280","author":"CD Willis","year":"2013","unstructured":"Willis CD, Poluzzi C, Mongiat M, Iozzo RV. Endorepellin laminin-like globular 1\/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells. FEBS J. 2013;280(10):2271\u201384.","journal-title":"FEBS J"},{"issue":"8","key":"1089_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1177\/1747493017701147","volume":"12","author":"GW Albers","year":"2017","unstructured":"Albers GW, Lansberg MG, Kemp S, et al. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017;12(8):896\u2013905.","journal-title":"Int J Stroke"},{"issue":"1","key":"1089_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1747493019830585","volume":"15","author":"ACO Tsang","year":"2020","unstructured":"Tsang ACO, You J, Li LF, et al. Burden of large vessel occlusion stroke and the service gap of thrombectomy: a population-based study using a territory-wide public hospital system registry. Int J Stroke. 2020;15(1):69\u201374.","journal-title":"Int J Stroke"},{"key":"1089_CR41","doi-asserted-by":"publisher","unstructured":"Cai Q, Xu G, Liu J, et al. A modification of intraluminal middle cerebral artery occlusion\/reperfusion model for ischemic stroke with laser Doppler flowmetry guidance in mice. Neuropsychiatr Dis Treat. 2016;12:2851\u20132858. Published 2016 Nov 3. https:\/\/doi.org\/10.2147\/NDT.S118531.","DOI":"10.2147\/NDT.S118531"},{"key":"1089_CR42","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1161\/STROKEAHA.114.006258","volume":"65","author":"J Springer","year":"2014","unstructured":"Springer J, Schust S, Peske K, et al. Catabolic signaling and muscle wasting after acute ischemic stroke. Indication for stroke-specific sarcopenia. Stroke. 2014;65:3675\u201383.","journal-title":"Stroke"},{"key":"1089_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2011.12.027","volume":"1438","author":"MG Saini","year":"2012","unstructured":"Saini MG, Bix GJ. Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B\/L mediated generation of neuroprotective perlecan LG3 by neurons. Brain Res. 2012;1438:65\u201374.","journal-title":"Brain Res"},{"issue":"3","key":"1089_CR44","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/jcsm.12400","volume":"10","author":"N Scherbakov","year":"2019","unstructured":"Scherbakov N, Pietrock C, Sandek A, Ebner N, Valentova M, Springer J, Schefold JC, von Haehling S, Anker SD, Norman K, Haeusler KG, Doehner W. Body weight changes and incidence of cachexia after stroke. J Cachexia Sarcopenia Muscle. 2019;10(3):611\u201320.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1089_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1161\/STROKEAHA.107.497602","volume":"39","author":"AC Jonsson","year":"2008","unstructured":"Jonsson AC, Lindgren I, Norring B, Lindgren A. Weight loss after stroke: a population-based study from the Lund Stroke Register. Stroke. 2008;39:918\u201323.","journal-title":"Stroke"},{"key":"1089_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbr.2009.08.011","volume":"205","author":"A Ferrara","year":"2009","unstructured":"Ferrara A, El Bejaoui S, Seyen S, Tirelli E, Plumier JC. The usefulness of operant conditioning procedures to assess long-lasting deficits following transient focal ischemia in mice. Behav Brain Res. 2009;205:525\u201334.","journal-title":"Behav Brain Res"},{"key":"1089_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1600-079X.2008.00568.x","volume":"45","author":"E Kilic","year":"2008","unstructured":"Kilic E, Kilic U, Bacigaluppi M, Guo Z, Abdallah NB, Wolfer DP. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res. 2008;45:142\u20138.","journal-title":"J Pineal Res"},{"issue":"2","key":"1089_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jht.2012.06.005","volume":"26","author":"CE Lang","year":"2013","unstructured":"Lang CE, Bland MD, Bailey RR, Schaefer SY, Birkenmeier RL. Assessment of upper extremity impairment, function, and activity after stroke: foundations for clinical decision making. J Hand Ther. 2013;26(2):104\u201314.","journal-title":"J Hand Ther"},{"issue":"4","key":"1089_CR49","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1191\/026921599676433080","volume":"3","author":"P Boissy","year":"1999","unstructured":"Boissy P, Bourbonnais D, Carlotti MM, Gravel D, Arsenault BA. Maximal grip force in chronic stroke subjects and its relationship to global upper extremity function. Clin Rehabil. 1999;3(4):354\u201362.","journal-title":"Clin Rehabil"},{"issue":"1","key":"1089_CR50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/brain\/awq344","volume":"134","author":"R Reitmeir","year":"2011","unstructured":"Reitmeir R, Kilic E, Kilic U, Bacigaluppi M, ElAli A, Salani G, Pluchino S, Gassmann M, Hermann DM. Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity. Brain. 2011;134(1):84\u201399.","journal-title":"Brain"},{"key":"1089_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1423-0127-21-5","volume":"21","author":"MJ Tsai","year":"2014","unstructured":"Tsai MJ, Tsai SK, Hu BR, Liou DY, Huang SL, Huang MC, Huang WC, Cheng H, Huang SS. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. J Biomed Sci. 2014;21:5.","journal-title":"J Biomed Sci"},{"issue":"7","key":"1089_CR52","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Hurst V, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 20. PLoS Biol. 2020;18(7):e3000411.","journal-title":"PLoS Biol"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-022-01089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T20:08:45Z","timestamp":1699733325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-022-01089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s12975-022-01089-2","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the STILLMEADOW, Inc. or Tulane University Institutional Animal Care and Use Committees. Planning, experimental procedures, group treatments, data analysis, documentation, and reporting were conducted in accordance with ARRIVE guidelines 2.0 ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors give their consent and approval for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"BC, GG and HDA are employees of Stream Biomedical Inc. which is actively exploring the therapeutic benefits of rhPDV and rhPDV<sub>LG3<\/sub>","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"BC, GG, and HDA are employees of Stream Biomedical Inc. which is actively exploring the therapeutic benefits of rhPDV and rhPDV<sub>LG3<\/sub>. All other authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}